1. CXCL12/CXCR4 Signaling Contributes to the Pathogenesis of Opioid Tolerance: A Translational Study. (March 2017) Authors: Lin, Chih-Peng; Kang, Kai-Hsiang; Tu, Huang-Ju; Wu, Ming-Yueh; Lin, Tzu-Hung; Liou, Houng-Chi; Sun, Wei-Zen; Fu, Wen-Mei Journal: Anesthesia & analgesia Issue: Volume 124:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach. (1st January 2021) Authors: Chao, Min-Wu; Lin, Tony Eight; HuangFu, Wei-Chun; Chang, Chao-Di; Tu, Huang-Ju; Chen, Liang-Chieh; Yen, Shih-Chung; Sung, Tzu-Ying; Huang, Wei-Jan; Yang, Chia-Ron; Pan, Shiow-Lin; Hsu, Kai-Cheng Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 36:Number 1(2021) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. (31st December 2023) Authors: Chang, Chao-Di; Chao, Min-Wu; Lee, Hsueh-Yun; Liu, Yi-Ting; Tu, Huang-Ju; Lien, Ssu-Ting; Lin, Tony Eight; Sung, Tzu-Ying; Yen, Shih-Chung; Huang, Sing-Han; Hsu, Kai-Cheng; Pan, Shiow-Lin Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 38:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗